Søgeresultater - Charles D. Blanke

Refine Results
  1. 1
    Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation [letter]

    Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation [letter] af Robert Hromas, Kenneth Cornetta, Edward F. Srour, Charles D. Blanke, ER Broun

    Udgivet 1994
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  2. 2
    Oxaliplatin: Hohe Aktivität in allen Stadien des Kolonkarzinoms

    Oxaliplatin: Hohe Aktivität in allen Stadien des Kolonkarzinoms af Paulo M. Hoff, Leonard B. Saltz, Charles D. Blanke, Eric van Custem

    Udgivet 2003
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  3. 3
    Association of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical Trials

    Association of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical Trials af Joseph M. Unger, Charles D. Blanke, Michael LeBlanc, Dawn L. Hershman

    Udgivet 2020
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  4. 4
    Cancer Clinical Trial Participation at the 1-Year Anniversary of the Outbreak of the COVID-19 Pandemic

    Cancer Clinical Trial Participation at the 1-Year Anniversary of the Outbreak of the COVID-19 Pandemic af Joseph M. Unger, Hong Xiao, Michael LeBlanc, Dawn L. Hershman, Charles D. Blanke

    Udgivet 2021
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  5. 5
    Characterizing 18 Years of the Death With Dignity Act in Oregon

    Characterizing 18 Years of the Death With Dignity Act in Oregon af Charles D. Blanke, Michael LeBlanc, Dawn L. Hershman, Lee M. Ellis, Frank L. Meyskens

    Udgivet 2017
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  6. 6
    Cetuximab as Second-Line Therapy in Patients with Metastatic Esophageal Adenocarcinoma: A Phase II Southwest Oncology Group Study (S0415)

    Cetuximab as Second-Line Therapy in Patients with Metastatic Esophageal Adenocarcinoma: A Phase II Southwest Oncology Group Study (S0415) af Philip J. Gold, Bryan Goldman, Syma Iqbal, Lawrence P. Leichman, Wu Zhang, Heinz‐Josef Lenz, Charles D. Blanke

    Udgivet 2010
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  7. 7
    Imatinib Plasma Levels Are Correlated With Clinical Benefit in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors

    Imatinib Plasma Levels Are Correlated With Clinical Benefit in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors af George D. Demetri, Yanfeng Wang, Elisabeth Wehrle, Amy Racine, Zariana Nikolova, Charles D. Blanke, Heikki Joensuu, Margaret von Mehren

    Udgivet 2009
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  8. 8
    A New Framework for Patient Engagement in Cancer Clinical Trials Cooperative Group Studies

    A New Framework for Patient Engagement in Cancer Clinical Trials Cooperative Group Studies af Patricia A. Deverka, Rick Bangs, Karma L. Kreizenbeck, Deborah M Delaney, Dawn L. Hershman, Charles D. Blanke, Scott D. Ramsey

    Udgivet 2018
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  9. 9
    Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer

    Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer af Syma Iqbal, Bryan Goldman, Cecilia M. Fenoglio‐Preiser, Heinz‐Josef Lenz, W. Zhang, K. D. Danenberg, Stephen Shibata, Charles D. Blanke

    Udgivet 2011
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  10. 10
    Let’s Talk About Those Herbs You Are Taking: Ethical Considerations for Communication With Patients With Cancer About Complementary and Alternative Medicine

    Let’s Talk About Those Herbs You Are Taking: Ethical Considerations for Communication With Patients With Cancer About Complementary and Alternative Medicine af Laura Tenner, Fay J. Hlubocky, Charles D. Blanke, Thomas W. LeBlanc, Jonathan M. Marron, Molly McGinnis, Rebecca Spence, Lynne P. Taylor

    Udgivet 2019
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  11. 11
    Trends in Medical Aid in Dying in Oregon and Washington

    Trends in Medical Aid in Dying in Oregon and Washington af Luai Al Rabadi, Michael LeBlanc, Taylor Bucy, Lee M. Ellis, Dawn L. Hershman, Frank L. Meyskens, Lynne P. Taylor, Charles D. Blanke

    Udgivet 2019
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  12. 12
    Cetuximab Plus Cisplatin, Irinotecan, and Thoracic Radiotherapy as Definitive Treatment for Locally Advanced, Unresectable Esophageal Cancer: A Phase-II Study of The SWOG (S0414)

    Cetuximab Plus Cisplatin, Irinotecan, and Thoracic Radiotherapy as Definitive Treatment for Locally Advanced, Unresectable Esophageal Cancer: A Phase-II Study of The SWOG (S0414) af Michael Tomblyn, Bryan Goldman, Charles R. Thomas, Jacqueline Benedetti, Heinz‐Josef Lenz, Vivek Mehta, Thaddeus Beeker, Philip J. Gold, James L. Abbruzzese, Charles D. Blanke

    Udgivet 2012
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  13. 13
    S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma

    S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma af Anthony B. El-Khoueiry, Cathryn Rankin, A.B. Siegel, Syma Iqbal, I-Y Gong, Kenneth C. Micetich, Omar Kayaleh, H-J Lenz, Charles D. Blanke

    Udgivet 2014
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  14. 14
    SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma

    SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma af Anthony B. El-Khoueiry, Cathryn Rankin, Edgar Ben‐Josef, Heinz‐Josef Lenz, Philip J. Gold, Robert D. Hamilton, Rangaswamy Govindarajan, Cathy Eng, Charles D. Blanke

    Udgivet 2011
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  15. 15
    Phase II study of the multitargeted antifolate LY231514 (ALIMTA™, MTA, pemetrexed disodium) in patients with advanced pancreatic cancer

    Phase II study of the multitargeted antifolate LY231514 (ALIMTA™, MTA, pemetrexed disodium) in patients with advanced pancreatic cancer af Kathy D. Miller, Joel Picus, Charles D. Blanke, William J. John, Jeffrey W. Clark, Lawrence N. Shulman, D. Thornton, Eric K. Rowinsky, Patrick J. Loehrer

    Udgivet 2000
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  16. 16
    Impact of Young Age on Treatment Efficacy and Safety in Advanced Colorectal Cancer: A Pooled Analysis of Patients From Nine First-Line Phase III Chemotherapy Trials

    Impact of Young Age on Treatment Efficacy and Safety in Advanced Colorectal Cancer: A Pooled Analysis of Patients From Nine First-Line Phase III Chemotherapy Trials af Charles D. Blanke, Brian M. Bot, David M. Thomas, Archie Bleyer, Claus-Henning Köhne, Michel Seymour, Aimery de Gramont, Richard M. Goldberg, Daniel J. Sargent

    Udgivet 2011
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  17. 17
    Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336)

    Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336) af Robert P. Whitehead, Cathryn Rankin, Paulo M. Hoff, Philip J. Gold, Kevin G. Billingsley, Robert Chapman, Lucas Wong, John H. Ward, James L. Abbruzzese, Charles D. Blanke

    Udgivet 2008
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  18. 18
    End Points in Advanced Colon Cancer Clinical Trials: A Review and Proposal

    End Points in Advanced Colon Cancer Clinical Trials: A Review and Proposal af Carmen J. Allegra, Charles D. Blanke, Marc Buyse, Richard M. Goldberg, Axel Grothey, Neal J. Meropol, Leonard B. Saltz, Alan P. Venook, Greg Yothers, Daniel J. Sargent

    Udgivet 2007
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  19. 19
    Dual blockade of epidermal growth factor receptor and insulin‐like growth factor receptor–1 signaling in metastatic pancreatic cancer: Phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotinib (SWOG S0727)

    Dual blockade of epidermal growth factor receptor and insulin‐like growth factor receptor–1 signaling in metastatic pancreatic cancer: Phase Ib and randomized phase II trial of gem... af Philip A. Philip, Bryan Goldman, Ramesh K. Ramanathan, Heinz‐Josef Lenz, Andrew M. Lowy, Robert P. Whitehead, Takeru Wakatsuki, Syma Iqbal, Rakesh Gaur, Jacqueline Benedetti, Charles D. Blanke

    Udgivet 2014
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  20. 20
    Phase 2 study of <scp>MK</scp>‐2206, an allosteric inhibitor of <scp>AKT</scp>, as second‐line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (<scp>S</scp>1005)

    Phase 2 study of <scp>MK</scp>‐2206, an allosteric inhibitor of <scp>AKT</scp>, as second‐line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative... af Ramesh K. Ramanathan, Shannon McDonough, Hagen F. Kennecke, Syma Iqbal, Joaquina Baranda, Tara Elisabeth Seery, Howard J. Lim, Aram F. Hezel, Gina M. Vaccaro, Charles D. Blanke

    Udgivet 2015
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:

Søgeredskaber: